Media coverage
4Media coverage
Title Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT(TM) Glioblastoma Clinical Trial and Expands Trial Sites Media name/outlet TD Ameritrade Country United States Date 7/28/20 Persons Andrew Brenner Title Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT Glioblastoma Clinical Trial and Expands Trial Sites Media name/outlet Wallstreet Online Country Germany Date 7/28/20 Persons Andrew Brenner Title Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT Glioblastoma Clinical Trial and Expands Trial Sites Media name/outlet India Pharma News Country India Date 7/28/20 Persons Andrew Brenner Title Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT„¢ Glioblastoma Clinical Trial and Expands Trial Sites Media name/outlet PrimeNewswire (Top News) Country United States Date 7/28/20 Persons Andrew Brenner